CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (47)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
2004 • 4,872 citations
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 • 3,585 citations
N<scp>aturally</scp>A<scp>rising</scp>CD4+R<scp>egulatory</scp>T C<scp>ells for</scp>I<scp>mmunologic</scp>S<scp>elf</scp>-T<scp>olerance and</scp>N<scp>egative</scp>C<scp>ontrol of</scp>I<scp>mmune</scp>R<scp>esponses</scp>
2003 • 3,323 citations
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 • 2,828 citations
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 • 2,667 citations
THE B7 FAMILY REVISITED
2005 • 2,239 citations
Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation
2000 • 2,211 citations
Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4
2000 • 2,207 citations
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 • 1,564 citations
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
1994 • 1,185 citations
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 • 1,033 citations
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 • 1,000 citations
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
2005 • 997 citations
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 • 981 citations
CTLA-4: new insights into its biological function and use in tumor immunotherapy
2002 • 923 citations
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
1996 • 917 citations
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signalsin vivo
2004 • 761 citations
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells
2001 • 743 citations
Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation
2005 • 716 citations
Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells
2004 • 680 citations
Identification of Regulatory T Cells in Tolerated Allografts
2002 • 577 citations
Cytotoxic T Lymphocyte Antigen-4 Accumulation in the Immunological Synapse Is Regulated by TCR Signal Strength
2002 • 497 citations
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 • 462 citations
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
2006 • 437 citations
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
2005 • 423 citations
CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation
1999 • 412 citations
CTLA-4 Regulates Induction of Anergy In Vivo
2001 • 409 citations
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 • 383 citations
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
2004 • 377 citations
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 • 375 citations
Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor
2005 • 371 citations
Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade
2005 • 331 citations
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 • 318 citations
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 • 307 citations
Activation requirements for the induction of CD4+CD25+ T cell suppressor function
2004 • 307 citations
CTLA-4 Blockade Reverses CD8+ T Cell Tolerance to Tumor by a CD4+ T Cell– and IL-2-Dependent Mechanism
1999 • 287 citations
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
1997 • 197 citations
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 • 157 citations
Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques
2003 • 128 citations
Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy
2004 • 119 citations
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+T cell responses
1999 • 115 citations
Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies.
2005 • 79 citations
CD25+CD4+ regulatory T cells exert in vitro suppressive activity independent of CTLA-4
2005 • 71 citations
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3[+]CD25[+]CD4[+] regulatory T cells
2006 • 70 citations
CTLA-4 Regulates Induction of Anergy In Vivo
2001 • 27 citations
A method that allows easy characterization of tumor-infiltrating lymphocytes
2001 • 24 citations
Functional Impairment of CD8 T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 • 18 citations
Cited By (0)
No citing papers found in database